Stock Quote
IMS Health Inc (RX) (NYSE Arca)
$21.56
2:01pm EST
+0.51%
$21.45
$21.60
2,322,863
$21.60
$21.48
$21.65
$10.85
1.06
8,168,468
| Name | Current Position | Compensation |
|---|---|---|
| Carlucci, David | Chairman of the Board, President, Chief Executive Officer | 5,663,183 |
| Pajot, Gilles | Vice Chairman of the Board | 3,925,623 |
| Katz, Leslye | Chief Financial Officer, Senior Vice President | 1,074,133 |
Profile
IMS Health Incorporated (IMS) is a provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers market intelligence products and services, including portfolio optimization capabilities; commercial effectiveness innovations; managed care and consumer health offerings,... Full Description
Company Address
IMS Health Inc
901 Main Avenue
Norwalk CT 06851
P: +1203.8455200
901 Main Avenue
Norwalk CT 06851
P: +1203.8455200
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Cegedim SA | €68.30 | -0.21 |
| Wolters Kluwer | €14.91 | +0.28 |
| RX | Industry | |
|---|---|---|
| P/E(TTM) | 13.69 | 6.24 |
| P/S(TTM) | 1.80 | 1.25 |
| ROI(TTM) | 18.08 | 5.10 |
| ROE(TTM) | -- | 6.18 |
| Consensus Recommendation | Hold |
|---|---|
| EPS Est. (Current Period) | 0.36 |
| EPS Est. (Current Year) | 1.57 |
| Total Revenue | $540.77M |
| Net Income | $-9.26M |
| EPS | $-0.05 |
